Literature DB >> 24631257

Barium chloride impaired Kir2.1 inward rectification in its stably transfected HEK 293 cell lines.

Naiji Shen1, Jifeng Zheng2, Hualiang Liu3, Kai Xu4, Qingmao Chen4, Yingying Chen5, Yueliang Shen5, Liqing Jiang2, Yuan Chen6.   

Abstract

Kir2.1 channel is a typical inward rectified channel with little outward currents when the membrane depolarized. Barium blocks the inward Kir2.1 currents in a voltage-dependent manner. However, in this study we found that barium would impair the rectification and open Kir2.1 outward currents at a depolarized voltage, causing increment of outward current amplitudes by 43±7% (n=5, P<0.01) after 200s barium application. In the meanwhile, a higher barium concentration did block the outward currents by 17.5±4.3% (n=4, P<0.01) and temporarily twisted current upward tendency. The increment was likely barium specific since both calcium and Kir2.1 specific blocker, Chloroethylclonidine (CEC), did not enhance the current amplitudes. The rectification of Kir2.1 was not recovered by washing barium off, which suggested a non-competitive mechanism. Since the currents occurred at phase 1, 2 of cardiac action potential, it would likely shorten the action potential plateau and it would decrease QT duration in electrocardiography (ECG).
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Barium; Cardiac action potential; Inward rectify; Kir2.1; Outward current

Mesh:

Substances:

Year:  2014        PMID: 24631257     DOI: 10.1016/j.ejphar.2014.02.025

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  2 in total

1.  Modeling an Excitable Biosynthetic Tissue with Inherent Variability for Paired Computational-Experimental Studies.

Authors:  Tanmay A Gokhale; Jong M Kim; Robert D Kirkton; Nenad Bursac; Craig S Henriquez
Journal:  PLoS Comput Biol       Date:  2017-01-20       Impact factor: 4.475

2.  Electrophysiological and Pharmacological Characterization of Human Inwardly Rectifying Kir2.1 Channels on an Automated Patch-Clamp Platform.

Authors:  Camille Sanson; Brigitte Schombert; Bruno Filoche-Rommé; Michel Partiseti; G Andrees Bohme
Journal:  Assay Drug Dev Technol       Date:  2019-03-05       Impact factor: 1.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.